XML 21 R12.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings Per Share
6 Months Ended
Jun. 30, 2023
Financial Instruments  
Earnings Per Share

NOTE 4 – EARNINGS PER SHARE

Earnings per share are based on the weighted average number of shares outstanding during the period. A computation of basic earnings per share and diluted earnings per share follows:

 

 

Three Months Ended

 

 

Six Months Ended

 

(Dollars in thousands, except share data)

June 30,

 

 

June 30,

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Basic

 

 

 

 

 

 

 

 

 

 

 

Net income

$

5,213

 

 

$

5,615

 

 

$

10,846

 

 

$

11,143

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

7,529,177

 

 

 

7,499,497

 

 

 

7,524,257

 

 

 

7,497,492

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per common shares

$

0.69

 

 

$

0.75

 

 

$

1.44

 

 

$

1.49

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted

 

 

 

 

 

 

 

 

 

 

 

Net income

$

5,213

 

 

$

5,615

 

 

$

10,846

 

 

$

11,143

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

7,529,177

 

 

 

7,499,497

 

 

 

7,524,257

 

 

 

7,497,492

 

Plus dilutive stock options and restricted stock units

 

22,720

 

 

 

11,027

 

 

 

28,335

 

 

 

13,766

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding and potentially dilutive shares

 

7,551,897

 

 

 

7,510,524

 

 

 

7,552,592

 

 

 

7,511,258

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per common share

$

0.69

 

 

$

0.75

 

 

$

1.44

 

 

$

1.49

 

 

There were 15,000 stock options and 5,125 performance awards that were considered anti-dilutive to earnings per share for the three months ended June 30, 2023. There were 15,000 stock options and 5,125 performance awards that were considered anti-dilutive to earnings per share for the six months ended June 30, 2023. There were 15,000 stock options, 28,660 restricted stock units, and 6,396 performance awards that were considered anti-dilutive to earnings per share for the three months ended June 30,2022. There were 15,000 stock options, 28,660 restricted stock units, and 6,396 performance awards that were considered anti-dilutive for the six months ended June 30, 2022.